Skip to main content
OpenTrials
Completed

NCT Number: NCT05200065

Thulium Laser Versus Bipolar Enucleation of the Prostate

Comparing the peri-operative outcomes in patients with benign prostatic hyperplasia (BPH) who will undergo bipolar enucleation of the prostate versus thulium laser enucleation.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Benign Prostatic Hyperplasia Genital Diseases Genital Diseases, Male Male Urogenital Diseases Prostatic Diseases Prostatic Hyperplasia Urogenital Diseases

Sex eligibility

Male

Study type

Interventional

Phase

Not applicable

Primary location

Kasr AlAiny School of Medicine

Cairo, Cairo Governorate, 11562, Egypt

About this study

  • Benign prostatic hyperplasia (BPH) is one of the most common and bothersome diseases influencing the quality of life of aging males. For decades, transurethral resection of the prostate (TURP) has been recognized as the standard treatment for BPH .Recently, endoscopic laser treatments of BPH has been developed as the result of advances in laser technology and better understanding of tissue-laser interactions and nowadays it represents a challenge for TURP as regards the peri-operative outcomes.
  • Both the European Association of Urology (EAU) and American Urological Association (AUA) recommend endoscopic enucleation of the prostate (EEP) as one of the techniques for management of benign prostatic hyperplasia (BPH) with various techniques that could be implemented including enbloc and three/two lobe enucleation.
  • The classical laser enucleation technique consists of a three-lobe enucleation of the adenoma with separate enucleation of the median and lateral lobes. Scoffone and Cracco developed an "en-bloc" enucleation technique for HoLEP (holmium laser enucleation) in 2016, showing a potential role to ease some difficult intraoperative steps of enucleation and to improve the learning curve and both of the techniques mentioned were found to be applicable for bipolar endoscopic enucleation as well.
  • Regarding the thulium laser physical properties; its wavelength is very close to the peak for absorption in water about 1940 nm being similar to the holmium laser wavelength which is about 2010 nm. However, unlike the pulsed wave holmium laser, this high density energy of thulium laser is best delivered in a continuous wave. This is translated into more efficient vaporization and shallower depth of penetration in tissue, which has been reported to be 0.2 mm as compared with 0.4 mm for holmium lasers. In thulium laser; the continuous wave mode is more suitable for hemostasis and coagulation of tissue, whereas the pulsed mode is more suited for lithotripsy.
  • BipolEP (Bipolar enucleation of the prostate) has been performed as an effective method for the management of BPH in some institutions. Bipolar enucleation of prostate is a done using energy source of a bipolar electrosurgical unit. Enucleated prostatic tissues are then removed with a morcellator.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with BPH who are unsatisfied with medical treatment having a Qmax of less than 15 cm/s.
  • Patients with BPH who had refractory retention.
  • Patients with complicated BPH (eg; chronic retention, refractory hematuria, bladder stones).
  • Prostate size of at least 80 grams or more.

Exclusion criteria

  • Patients with a bladder mass.
  • Patients with prostate cancer.
  • Patients suffering from a urethral stricture.
  • Patients with previous endoscopic or surgical prostate intervention.
  • Prostate size less than 80 grams.

Treatment and study plan

Thulium Laser Enucleation of the Prostate

Procedure

Using the thulium laser to achieve complete endoscopic enucleation of the prostate.

Bipolar enucleation of the prostate

Procedure

Using the bipolar plasma energy to achieve complete endoscopic enucleation of the prostate.

Primary outcomes

  1. Effect on the operative time and other intra-operative and post-operative parameters

    Time frame: 3 to 6 month

    Effect of the chosen technique on the operative time including both enucleation and morcellation times.

    The occurrence of any inta-operative complications including significant blood loss necessitating blood transfusion, capsular perforation, sub-trigonal dissection and complications related to morcellation for example bladder perforation.

    The occurrence of any post-operative complications which is divided into either immediate post-operative and long term complications.

    Immediate post-operative complications occurring in the first 48 hours after enucleation include affection of the hemodynamics and vital signs of the patient, drop in hemoglobin level, high grade fever or uro-sepsis, retention with re-catheterization, hematuria with clot retention.

    long term complications occurring include persistent urge or stress urinary incontinence, secondary hemorrhage with hematuria and clot retention, recurrent urinary tract infections, urethral stricture or bladder neck contracture.

Secondary outcomes

  1. Change of the urine flow of the patients.

    Time frame: 3 to 6 month

    Improvement of the uroflowmetry parameters after catheter removal especially the Qmax (maximum flow rate), Qavg (Average flow rate) in addition to a bell shaped curve in the flowmetry plotted curve.

  2. Change of the IPSS (International Prostatic Symptom Score) of the patients

    Time frame: 3 to 6 month

    Improvement of the IPSS score of the patients after catheter removal compared to the value of the IPSS before enucleation.

    Values of the IPSS:

    Mild Symptoms from 1 to 7 Moderate Symptoms from 8 to 19 Severe Symptoms from 20 to 35

  3. Change of residual urine volume after surgery

    Time frame: 3 to 6 month

    Reduction in the amount of residual urine by US after catheter removal below 150 cc.

Sponsors and collaborators

Lead sponsor

Cairo University

Other

Registry information

Official study title

Prospective Randomized Study Comparing the Intra-operative and Post-operative Outcomes of Bipolar Enucleation of the Prostate Versus Thulium Laser Enucleation

Important dates

Study start
2021
Primary completion
2022
Study completion
2022
First posted
Jan 20, 2022
Registry last updated
Jun 23, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.